6Park YN, Roncalli M. Large liver cell dysplasia: a controversial entity[J]. Hepatol, 2006, 45(5):734-743.
7Libbrecht L, Desmet V, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis[J]. Liver Int, 2005, 25(1): 16-27.
8Plentz RR, Park YN, Lechel A, et al. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis[J]. Hepatology, 2007, 45 (4): 968-976.
9Lin CC, Lin C J, Hsu CW, et al. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades [DB/OL]. Journal of Gastroenterology and Hepatology, (2007-03 -27) [2007-9-18].http://www.blackwell-synergy.com/doi/abs/10.1111/j. 1440-1746.2007.04924.x
10Nam SW, Park JY, Ramasamy A, et al. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling[J]. Hepatology, 2005, 42 (4):809-818.
3Research Center of Clinical Medicine,Affiliated Hospital of Nantong University,Nantong 226001,China (Yao M,Yao DF,Qiu LW,Wu W,Sai WL,Yang JL and Zhang HJ),Department of Oncology,Yancheng First People’s Hospital,Yancheng 224001,China (Bian YZ),Department of Oncology,Second Affiliated Hospital,Nanjing Medical University,Nanjing 210011,China (Zhang CG).Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(3):289-294. 被引量：52
